Angiodynamic Inc
ANGO - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$504.23M
Close$
$3.83
67.5% downside
Current Fair Value
67.5% downsideOvervalued by 67.5% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $504.23 Million |
|---|---|
| Enterprise Value | $481.00 Million |
| Earnings per Share | $-0.88 |
| Beta | 0.3 |
| Outstanding Shares | 42,022,000 |
Return
| Return on Equity | -20.09% |
|---|---|
| Return on Assets | -13.61% |
| Return on Invested Capital | -12.80% |
Valuation & Multiples
| P/E Ratio | -15.18 |
|---|---|
| PEG | 43.48 |
| Price to Sales | 1.68 |
| Price to Book Ratio | 3.92 |
| Enterprise Value to Revenue | 1.48 |
| Enterprise Value to EBIT | -20.61 |
| Enterprise Value to Net Income | -15 |
| Total Debt to Enterprise | 0.02 |
| Debt to Equity | 0.07 |
Revenue Sources
No data
Last Earnings Call
Report Date
October 8, 2026
EPS Estimate
$-0.11
Consensus analyst estimateRevenue Estimate
$80.51 M
Consensus analyst estimateNext Earnings Call
Expected Date
January 5, 2027
EPS Estimate
$-0.09
Consensus analyst estimateRevenue Estimate
$84.03 M
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 4.18%▼ 88.03% |
|---|---|
| Total Invested | $26.60M▼ 94.66% |
| Investors Holding | 31▼ 132.00% |
About Angiodynamic Inc
CEO: James Clemmer
AngioDynamics, Inc. is a leading provider of innovative, minimally invasive medical devices used by professional healthcare providers for vascular access, peripheral vascular disease, and oncology. AngioDynamics' diverse product lines in...